Legal & General Group Plc Sells 42,629 Shares of Humana Inc. $HUM

Legal & General Group Plc cut its position in Humana Inc. (NYSE:HUM) by 4.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 876,325 shares of the insurance provider’s stock after selling 42,629 shares during the quarter. Legal & General Group Plc’s holdings in Humana were worth $224,453,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Sound View Wealth Advisors Group LLC grew its stake in shares of Humana by 3.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after buying an additional 36 shares in the last quarter. Unison Advisors LLC grew its stake in shares of Humana by 0.4% in the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock valued at $2,646,000 after buying an additional 37 shares in the last quarter. CoreCap Advisors LLC boosted its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Insigneo Advisory Services LLC boosted its position in Humana by 3.0% during the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after purchasing an additional 43 shares during the period. Finally, Columbus Macro LLC boosted its position in Humana by 5.5% during the fourth quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock worth $210,000 after purchasing an additional 43 shares during the period. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on HUM. Wolfe Research cut shares of Humana from a “strong-buy” rating to a “peer perform” rating in a research report on Wednesday, May 20th. TD Cowen lifted their price objective on shares of Humana from $173.00 to $211.00 and gave the stock a “hold” rating in a research report on Friday, May 1st. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Needham & Company LLC began coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating for the company. Finally, Seaport Research Partners cut shares of Humana to a “neutral” rating in a research report on Wednesday, May 20th. Nine research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $270.48.

Humana Trading Up 1.8%

Shares of Humana stock opened at $307.13 on Thursday. The firm has a 50-day moving average of $226.50 and a 200-day moving average of $228.10. The stock has a market cap of $36.87 billion, a PE ratio of 32.85, a PEG ratio of 2.19 and a beta of 0.68. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.66. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts forecast that Humana Inc. will post 9.01 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.